EMA Authorised: Qutenza (capsaicin) — Grunenthal GmbH

View source ↗

Summary

The EMA authorised Qutenza (capsaicin) from Grunenthal GmbH for neuralgia in the European Union.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuralgia

Drugs mentioned

• QUTENZA (Capsaicin)

Snippet

Status: Authorised. Therapeutic area: Neuralgia. MAH: Grunenthal GmbH. Decision date: 12/02/2026